In addition, CXCL16 neutralization antibody (AF976; R&D Systems) and CXCL10 neutralization antibody (MAB266; R&D Systems) were used to block CXCL16 or CXCL10; CXCR6−CD8+ T cells and CXCR3−CD8+ T cells derived from patients with vitiligo were also used for the migration assay. Plates...